The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA Sends Warning Letters to More Than 50 GLP 1 Compounders and Manufacturers Wilson Sonsini Approval Letter BLA 761040 BPC 157: The peptide with big claims and scant evidence STAT BPC 157: Experimental Peptide Creates Risk for Athletes